ALAS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ALAS Antibodies for investigating aminolevulinate synthase (ALAS) in biological processes. ALAS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aminolevulinate synthase functions as a key enzyme in the heme biosynthesis pathway, catalyzing the first step in producing porphyrins, which are essential for hemoglobin and other heme-containing proteins. ALAS regulation maintains cellular heme levels, and disruption can result in various disorders, including porphyrias and anemia. Research focused on ALAS activity provides insights into the mechanisms underlying these conditions. Understanding ALAS function advances knowledge about heme-related disorders and supports the development of therapeutic approaches. Investigating ALAS expression patterns helps reveal its role in different tissues and cellular processes. ALAS research contributes to understanding metabolic pathways and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of heme biosynthesis and related diseases.